Healthcare provider profile · identity verified

Dale Hursh, MD

Geriatric Medicine · LANCASTER, PA · NPI 1831154178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	475	48
Amlodipine Besylate	Amlodipine Besylate	450	62
Levothyroxine Sodium	Levothyroxine Sodium	439	55
Furosemide	Furosemide	404	49
Atorvastatin Calcium	Atorvastatin Calcium	392	50
Sertraline Hcl	Sertraline Hcl	357	46
Metoprolol Succinate	Metoprolol Succinate	320	42
Eliquis	Apixaban	298	24
Gabapentin	Gabapentin	285	31
Lisinopril	Lisinopril	280	40
Potassium Chloride	Potassium Chloride	231	27
Mirtazapine	Mirtazapine	226	32
Pantoprazole Sodium	Pantoprazole Sodium	226	18
Donepezil Hcl	Donepezil Hcl	189	21
Losartan Potassium	Losartan Potassium	183	25
Metoprolol Tartrate	Metoprolol Tartrate	182	26
Latanoprost	Latanoprost	178	22
Clopidogrel	Clopidogrel Bisulfate	149	18
Quetiapine Fumarate	Quetiapine Fumarate	132	15
Duloxetine Hcl	Duloxetine Hcl	127	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	126	suppressed
Warfarin Sodium	Warfarin Sodium	121	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	116	18
Carbidopa-Levodopa	Carbidopa/Levodopa	111	14
Metformin Hcl	Metformin Hcl	108	13
Finasteride	Finasteride	106	13
Famotidine	Famotidine	99	16
Venlafaxine Hcl Er	Venlafaxine Hcl	97	suppressed
Memantine Hcl	Memantine Hcl	96	14
Alendronate Sodium	Alendronate Sodium	86	suppressed
Simvastatin	Simvastatin	86	13
Diclofenac Sodium	Diclofenac Sodium	79	18
Spironolactone	Spironolactone	78	11
Oxycodone Hcl	Oxycodone Hcl	73	20
Escitalopram Oxalate	Escitalopram Oxalate	69	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	69	13
Citalopram Hbr	Citalopram Hydrobromide	60	suppressed
Myrbetriq	Mirabegron	60	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	suppressed
Clonazepam	Clonazepam	58	suppressed
Trazodone Hcl	Trazodone Hcl	56	suppressed
Prednisone	Prednisone	55	suppressed
Lorazepam	Lorazepam	54	17
Carvedilol	Carvedilol	53	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	51	14
Pravastatin Sodium	Pravastatin Sodium	50	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	47	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	46	12
Lamotrigine	Lamotrigine	45	suppressed
Risperidone	Risperidone	45	suppressed
Bupropion Xl	Bupropion Hcl	43	suppressed
Tradjenta	Linagliptin	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Nystatin	Nystatin	40	27
Olanzapine	Olanzapine	40	suppressed
Nifedipine Er	Nifedipine	39	suppressed
Nyamyc	Nystatin	38	14
Valsartan	Valsartan	38	suppressed
Alprazolam	Alprazolam	37	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	36	suppressed
Benazepril Hcl	Benazepril Hcl	36	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	34	suppressed
Nuplazid	Pimavanserin Tartrate	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Ketoconazole	Ketoconazole	31	15
Atenolol	Atenolol	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Hydrocortisone	Hydrocortisone	29	24
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	27	suppressed
Ondansetron Odt	Ondansetron	27	21
Tramadol Hcl	Tramadol Hcl	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	16
Bumetanide	Bumetanide	24	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Bupropion Hcl	Bupropion Hcl	23	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	23	18
Midodrine Hcl	Midodrine Hcl	23	suppressed
Restasis	Cyclosporine	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Primidone	Primidone	22	suppressed
Timolol Maleate	Timolol Maleate	22	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	21	suppressed
Morphine Sulfate	Morphine Sulfate	21	14
Novolog Flexpen	Insulin Aspart	21	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Travoprost	Travoprost	20	suppressed
Amoxicillin	Amoxicillin	19	14
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	19	suppressed
Rytary	Carbidopa/Levodopa	18	suppressed
Baclofen	Baclofen	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Estradiol	Estradiol	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nitroglycerin	Nitroglycerin	16	13
Torsemide	Torsemide	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Dapsone	Dapsone	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Movantik	Naloxegol Oxalate	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Sodium Fluoride	Fluoride (Sodium)	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Topiramate	Topiramate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Digoxin	Digoxin	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	11
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Prednisolone Acetate	Prednisolone Acetate	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error